Park Avenue Securities’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Sell
45,600
-4,765
-9% -$213K 0.01% 697
2026
Q1
$2.43M Sell
50,365
-3,621
-7% -$169K 0.02% 498
2025
Q4
$2.62M Buy
53,986
+759
+1% +$37.6K 0.02% 455
2025
Q3
$2.51M Sell
53,227
-6,003
-10% -$290K 0.02% 504
2025
Q2
$2.86M Buy
59,230
+3,687
+7% +$188K 0.03% 412
2025
Q1
$3.08M Sell
55,543
-13,439
-19% -$727K 0.04% 287
2024
Q4
$3.33M Buy
68,982
+8,615
+14% +$438K 0.03% 329
2024
Q3
$3.48M Sell
60,367
-7,686
-11% -$415K 0.04% 289
2024
Q2
$3.3M Buy
68,053
+4,542
+7% +$219K 0.04% 279
2024
Q1
$3.09M Buy
63,511
+6,802
+12% +$332K 0.04% 289
2023
Q4
$2.82M Sell
56,709
-7,797
-12% -$381K 0.04% 282
2023
Q3
$3.46M Buy
64,506
+2,135
+3% +$114K 0.05% 217
2023
Q2
$3.36M Buy
62,371
+1,692
+3% +$91K 0.05% 221
2023
Q1
$3.3M Buy
60,679
+10,745
+22% +$523K 0.06% 203
2022
Q4
$2.42M Sell
49,934
-1,906
-4% -$83.7K 0.04% 256
2022
Q3
$1.97M Sell
51,840
-2,289
-4% -$102K 0.04% 272
2022
Q2
$2.71M Buy
54,129
+12,903
+31% +$685K 0.05% 212
2022
Q1
$2.12M Buy
41,226
+11,872
+40% +$613K 0.04% 269
2021
Q4
$1.47M Buy
29,354
+5,293
+22% +$262K 0.03% 340
2021
Q3
$1.16M Buy
24,061
+6,232
+35% +$317K 0.02% 366
2021
Q2
$939K Buy
17,829
+3,860
+28% +$201K 0.02% 414
2021
Q1
$691K Buy
13,969
+3,474
+33% +$167K 0.02% 484
2020
Q4
$510K Buy
10,495
+2,636
+34% +$130K 0.01% 496
2020
Q3
$394K Buy
7,859
+700
+10% +$36K 0.01% 496
2020
Q2
$365K Buy
7,159
+1,348
+23% +$65.5K 0.01% 453
2020
Q1
$254K Buy
5,811
+1,093
+23% +$52.3K 0.02% 258
2019
Q4
$237K Buy
+4,718
New +$221K 0.01% 524
2018
Q3
Sell
-6,617
Closed -$265K 224
2018
Q2
$265K Buy
+6,617
New +$261K 0.05% 128
2017
Q4
Sell
-4,404
Closed -$219K 136
2017
Q3
$219K Sell
4,404
-675
-13% -$32.7K 0.07% 88
2017
Q2
$245K Buy
+5,079
New +$243K 0.03% 170
2017
Q1
Sell
-5,525
Closed -$227K 68
2016
Q4
$227K Buy
+5,525
New +$218K 0.11% 46

Other funds holding SNY

Park Avenue Securities's SNY Position: Q2 2026 in Review

Park Avenue Securities reduced its Sanofi (SNY) stake by 9.5% in Q2 2026, selling an estimated $213K and leaving 45,600 shares worth $1.95M. The position accounts for 0.01% of the portfolio, ranked #697.

Park Avenue Securities first reported a position in SNY in Q4 2016 and has held it in 31 quarters since. The position peaked at $3.48M in Q3 2024. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Park Avenue Securities held 45,600 shares of Sanofi worth $1.95M as of Q2 2026.
  • Park Avenue Securities sold 4,765 Sanofi shares in Q2 2026, an estimated $213K.
  • Sanofi made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #697 holding.
  • Park Avenue Securities first reported a position in Sanofi in Q4 2016 and has held it in 31 quarters since.
  • Park Avenue Securities's Sanofi position peaked at $3.48M in Q3 2024.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.